Primary Biliary Cirrhosis
73
5
8
42
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
14 trials with published results (19%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.1%
3 terminated out of 73 trials
93.3%
+6.8% vs benchmark
26%
19 trials in Phase 3/4
33%
14 of 42 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 42 completed trials
Clinical Trials (73)
Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Biobank for Cholestatic Liver Diseases.
Repeatability and Reproducibility of Multiparametric MRI
Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
TruGraf Liver Gene Expression Serial Test
The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis
Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia
Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis
A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384
An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects
Online Wellness Intervention for Primary Biliary Cholangitis (PBC)
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis
sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis